These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 9783967)

  • 1. The impact of treated dysfunctional voiding on the nonsurgical management of vesicoureteral reflux.
    Snodgrass W
    J Urol; 1998 Nov; 160(5):1823-5. PubMed ID: 9783967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing concepts concerning the management of vesicoureteral reflux.
    Herndon CD; DeCambre M; McKenna PH
    J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder malfunction, urinary tract infection and vesicoureteral reflux in children].
    Castro I; Soares E; Casimiro A; Nogueira G
    Acta Med Port; 1998 Jul; 11(7):635-42. PubMed ID: 9859510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction.
    Upadhyay J; Bolduc S; Bagli DJ; McLorie GA; Khoury AE; Farhat W
    J Urol; 2003 May; 169(5):1842-6; discussion 1846; author reply 1846. PubMed ID: 12686859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with vesicoureteral reflux in children: clinical characteristics.
    Greenfield SP; Ng M; Wan J
    J Urol; 1997 Aug; 158(2):574-7. PubMed ID: 9224365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
    Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
    J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children.
    Chen JJ; Mao W; Homayoon K; Steinhardt GF
    J Urol; 2004 May; 171(5):1907-10. PubMed ID: 15076307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.
    Van Batavia JP; Ahn JJ; Fast AM; Combs AJ; Glassberg KI
    J Urol; 2013 Oct; 190(4 Suppl):1495-9. PubMed ID: 23416636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of biofeedback treatment on reflux resolution rates in children with dysfunctional voiding and vesicoureteral reflux.
    Kibar Y; Ors O; Demir E; Kalman S; Sakallioglu O; Dayanc M
    Urology; 2007 Sep; 70(3):563-6; discussion 566-7. PubMed ID: 17905115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.
    Swerkersson S; Jodal U; Sixt R; Stokland E; Hansson S
    J Urol; 2007 Aug; 178(2):647-51; discussion 650-1. PubMed ID: 17574623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of targeted treatment for vesicoureteral reflux in children with nonneurogenic lower urinary tract dysfunction.
    Fast AM; Nees SN; Van Batavia JP; Combs AJ; Glassberg KI
    J Urol; 2013 Sep; 190(3):1028-32. PubMed ID: 23473909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and functional abnormalities linked with recurrent urinary tract infections in girls.
    Mazzola BL; von Vigier RO; Marchand S; Tönz M; Bianchetti MG
    J Nephrol; 2003; 16(1):133-8. PubMed ID: 12649544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of grades III and IV primary vesicoureteral reflux in children with and without acute pyelonephritis as breakthrough infections: a comparative analysis.
    Yu TJ; Chen WF
    J Urol; 1997 Apr; 157(4):1404-6. PubMed ID: 9120964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux.
    Cooper CS; Chung BI; Kirsch AJ; Canning DA; Snyder HM
    J Urol; 2000 Jan; 163(1):269-72; discussion 272-3. PubMed ID: 10604374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of high bladder pressure on vesicoureteral reflux and its resolution.
    Acar B; Arikan FI; Germiyanoğlu C; Dallar Y
    Urol Int; 2009; 82(1):77-80. PubMed ID: 19172102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux.
    Thompson RH; Chen JJ; Pugach J; Naseer S; Steinhardt GF
    J Urol; 2001 Oct; 166(4):1465-9. PubMed ID: 11547114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Swedish reflux trial in children: III. Urinary tract infection pattern.
    Brandström P; Esbjörner E; Herthelius M; Swerkersson S; Jodal U; Hansson S
    J Urol; 2010 Jul; 184(1):286-91. PubMed ID: 20488494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is age at toilet training associated with the presence of vesicoureteral reflux or the occurrence of urinary tract infection?
    Chen JJ; Ahn HJ; Steinhardt GF
    J Urol; 2009 Jul; 182(1):268-71. PubMed ID: 19450811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder dynamics and vesicoureteral reflux: factors associated with idiopathic lower urinary tract dysfunction in children.
    Ural Z; Ulman I; Avanoglu A
    J Urol; 2008 Apr; 179(4):1564-7. PubMed ID: 18295262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.